Citation Impact 2023
Journal Impact Factor: 7.0
5-year Journal Impact Factor: 8.7
Source Normalized Impact per Paper (SNIP): 2.000
SCImago Journal Rank (SJR): 2.711
Speed 2023
Submission to first editorial decision (median days): 6
Submission to acceptance (median days): 145
Usage 2023
Downloads: 6,375,113
Altmetric mentions: 24,228
IL-2-free tumor-infiltrating lymphocyte therapy with PD-1 blockade demonstrates potent efficacy in advanced gynecologic cancer
Tumor-infiltrating lymphocyte (TIL) therapy has been restricted by intensive lymphodepletion and high-dose intravenous interleukin-2 (IL-2) administration. To address these limitations, we conducted preclinica...